We are live on
!
Find out more
GWCM
Godshalk Welsh Capital Management Portfolio holdings
AUM
$172M
1-Year Est. Return
16.03%
This Fund
S&P 500
This Quarter
Est. Return
+3.16%
1 Year Est. Return
+16.03%
3 Year Est. Return
+54.69%
5 Year Est. Return
+73.83%
10 Year Est. Return
+285.52%
AUM
$150M
AUM Growth
+$1.17M
(+0.78%)
Cap. Flow
-$1.69M
Cap. Flow
% of AUM
-1.13%
Top 10 Holdings %
Top 10 Hldgs %
35.26%
Holding
125
New
4
Increased
26
Reduced
47
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
|
+$328K |
| 2 |
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
|
+$267K |
| 3 |
IBDP
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
|
+$208K |
| 4 |
Analog Devices
ADI
|
+$196K |
| 5 |
Carrier Global
CARR
|
+$195K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$893K |
| 2 |
Invesco QQQ Trust
QQQ
|
+$615K |
| 3 |
Globus Medical
GMED
|
+$274K |
| 4 |
Bristol-Myers Squibb
BMY
|
+$239K |
| 5 |
Genuine Parts
GPC
|
+$217K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.94% |
| 2 | Financials | 11.5% |
| 3 | Healthcare | 11.32% |
| 4 | Consumer Staples | 11% |
| 5 | Consumer Discretionary | 6.22% |
Similar funds
PWM
TA
CRFG
BAM
PSC
RPSM
MC
BIA
Godshalk Welsh Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, Godshalk Welsh Capital Management held 125 positions worth $150M, up 0.78% from $149M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Godshalk Welsh Capital Management's Q2 2024 filing shows 4 new, 26 increased, 47 reduced and 6 closed positions. Its largest new stake was iShares iBonds Dec 2024 Term Corporate ETF: 8,300 shares worth $209K. The largest sale was CVS Health, an estimated $893K.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Godshalk Welsh Capital Management's largest Q2 2024 buy was iShares iBonds Dec 2024 Term Corporate ETF: 8,300 shares worth $209K.
- Godshalk Welsh Capital Management added most to iShares iBonds Dec 2027 Term Corporate ETF in Q2 2024, an estimated $328K increase.
- Godshalk Welsh Capital Management's biggest Q2 2024 reduction was Globus Medical, cutting an estimated $274K.
- Godshalk Welsh Capital Management fully exited CVS Health in Q2 2024, selling an estimated $893K.
- Godshalk Welsh Capital Management's ten largest holdings make up 35% of its $150M portfolio in Q2 2024.
- Godshalk Welsh Capital Management opened 4 new positions and closed 6 in Q2 2024.
- Godshalk Welsh Capital Management's portfolio value rose 0.78% quarter-over-quarter to $150M.
Based on Godshalk Welsh Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.